US charges drug researchers with sending trade secrets to China but will

first_imgAttorneys are urging caution in evaluating the strength of a U.S. trade secrets case against two GlaxoSmithKline (GSK) scientists who were accused last week of transferring trade secrets to China. The case bears some similarities, they say, to other recent cases involving Chinese American or Chinese defendants in which federal prosecutors abruptly dropped charges because of improper analysis or insufficient evidence.Last week, federal prosecutors in Philadelphia, Pennsylvania, announced the indictments of biomedical researchers Yu Xue and Lucy Xi, as well as three associates, for trade secrets theft, wire fraud, and other charges.  The scientists stand accused of emailing and downloading proprietary data about GSK products and sending it to contacts working for the Chinese startup Renopharma, which provides contract research services for early drug discovery, according to its website. Xue, the key scientist in the GSK endeavor and a researcher in the company’s Upper Merion, Pennsylvania, research center, told an acquaintance that she owned a 30% stake in Renopharma. The 66-page indictment, released 20 January, details emails and messages sent among the defendants over a 3-year period, and alleges that Xue hoped to profit off the transfer of information. Country * Afghanistan Aland Islands Albania Algeria Andorra Angola Anguilla Antarctica Antigua and Barbuda Argentina Armenia Aruba Australia Austria Azerbaijan Bahamas Bahrain Bangladesh Barbados Belarus Belgium Belize Benin Bermuda Bhutan Bolivia, Plurinational State of Bonaire, Sint Eustatius and Saba Bosnia and Herzegovina Botswana Bouvet Island Brazil British Indian Ocean Territory Brunei Darussalam Bulgaria Burkina Faso Burundi Cambodia Cameroon Canada Cape Verde Cayman Islands Central African Republic Chad Chile China Christmas Island Cocos (Keeling) Islands Colombia Comoros Congo Congo, the Democratic Republic of the Cook Islands Costa Rica Cote d’Ivoire Croatia Cuba Curaçao Cyprus Czech Republic Denmark Djibouti Dominica Dominican Republic Ecuador Egypt El Salvador Equatorial Guinea Eritrea Estonia Ethiopia Falkland Islands (Malvinas) Faroe Islands Fiji Finland France French Guiana French Polynesia French Southern Territories Gabon Gambia Georgia Germany Ghana Gibraltar Greece Greenland Grenada Guadeloupe Guatemala Guernsey Guinea Guinea-Bissau Guyana Haiti Heard Island and McDonald Islands Holy See (Vatican City State) Honduras Hungary Iceland India Indonesia Iran, Islamic Republic of Iraq Ireland Isle of Man Israel Italy Jamaica Japan Jersey Jordan Kazakhstan Kenya Kiribati Korea, Democratic People’s Republic of Korea, Republic of Kuwait Kyrgyzstan Lao People’s Democratic Republic Latvia Lebanon Lesotho Liberia Libyan Arab Jamahiriya Liechtenstein Lithuania Luxembourg Macao Macedonia, the former Yugoslav Republic of Madagascar Malawi Malaysia Maldives Mali Malta Martinique Mauritania Mauritius Mayotte Mexico Moldova, Republic of Monaco Mongolia Montenegro Montserrat Morocco Mozambique Myanmar Namibia Nauru Nepal Netherlands New Caledonia New Zealand Nicaragua Niger Nigeria Niue Norfolk Island Norway Oman Pakistan Palestine Panama Papua New Guinea Paraguay Peru Philippines Pitcairn Poland Portugal Qatar Reunion Romania Russian Federation Rwanda Saint Barthélemy Saint Helena, Ascension and Tristan da Cunha Saint Kitts and Nevis Saint Lucia Saint Martin (French part) Saint Pierre and Miquelon Saint Vincent and the Grenadines Samoa San Marino Sao Tome and Principe Saudi Arabia Senegal Serbia Seychelles Sierra Leone Singapore Sint Maarten (Dutch part) Slovakia Slovenia Solomon Islands Somalia South Africa South Georgia and the South Sandwich Islands South Sudan Spain Sri Lanka Sudan Suriname Svalbard and Jan Mayen Swaziland Sweden Switzerland Syrian Arab Republic Taiwan Tajikistan Tanzania, United Republic of Thailand Timor-Leste Togo Tokelau Tonga Trinidad and Tobago Tunisia Turkey Turkmenistan Turks and Caicos Islands Tuvalu Uganda Ukraine United Arab Emirates United Kingdom United States Uruguay Uzbekistan Vanuatu Venezuela, Bolivarian Republic of Vietnam Virgin Islands, British Wallis and Futuna Western Sahara Yemen Zambia Zimbabwe Email The indictment alleges that Xue helped Renopharma obtain her and others’ research into the anti-HER3 antibody. In one seized email from 2012, she hints that her connection to GSK makes her “the core figure” in Renopharma. In another instance, she writes, “Although I am not resigning from my position to go back [to China] at the initial stage, my time and energy spent is not going to be less than anyone else’s. As a matter of fact, it will only be more.”The case comes on the heels of several high-profile investigations into Chinese or Chinese American scientists in which prosecutors have abruptly dropped charges, sparking accusations of racial profiling. This past September, prosecutors dropped charges against Xiaoxing Xi, the interim chair of Temple University’s physics department, after experts submitted affidavits suggesting that his alleged crimes were merely standard scientific collaborations.Some of the same actors from Xi’s case have resurfaced this time around. As in that earlier case, the GSK case was investigated by FBI Special Agent Andrew Haugen, complaints show. Both cases were also brought by the Philadelphia U.S. Attorney’s Office.The question now, says Peter Toren, a litigator with Weisbrod Matteis & Copley in Washington, D.C., who specializes in trade secrets cases, is whether the U.S. Attorney’s Office has learned from its mistakes. “Hopefully they did a better job of investigating the information before charging somebody who does not really have anything to do with stealing trade secrets,” he says.Indeed, an affidavit Haugen filed in seeking arrest warrants states that although FBI investigators relied primarily on GSK guidance in establishing that the knowledge involved was trade secrets, they also consulted an outside expert who is not affiliated with the pharmaceutical giant. In the case of Xi, the physicist, the government apparently did not confer with outside experts before proceeding with the indictment.Xue, for her part, has hired Peter Zeidenberg, a defense attorney at Arent Fox in Washington, D.C., who is quickly becoming the go-to lawyer for Chinese scientists accused of trade secrets crimes. Zeidenberg successfully represented both Xi and Sherry Chen, a National Weather Service hydrologist accused of passing information about the national dam system to a Chinese official.“My client is not guilty and is pleading not guilty and will be contesting the charges,” Zeidenberg told ScienceInsiderOther aspects of the current case evoke another botched case: the 2013 prosecution of former Eli Lilly scientists Guoqing Cao and Shuyu Li. They, too, were accused of passing on company information to a Chinese competitor. According to filings by defense attorneys in the case, the information had all appeared in published papers years earlier and did not include data or formulae owned by Eli Lilly. In December 2014, prosecutors dropped charges.Only time will tell whether this latest prosecution will snag the Justice Department a victory or will prove a repeat of those earlier cases. “The government in this particular case may have very strong evidence,” Toren says. “But the crucial factor may be whether the information that the government is accusing these individuals of obtaining and transferring to China is in fact a trade secret.” Click to view the privacy policy. Required fields are indicated by an asterisk (*) Sign up for our daily newsletter Get more great content like this delivered right to you! Country The alleged trade secrets involve biopharmaceutical drugs, or proteins that bind to receptor cells and cause a cell to behave in a certain manner. Xue, who holds a doctoral degree in biological chemistry from the University of North Carolina, Chapel Hill, was “one of the top protein biochemists in the world,” according to the indictment. She helped lead a GSK project focused on designing a monoclonal antibody to link to the HER3 receptor on human cells as a treatment for cancer.last_img

Leave a Reply

Your email address will not be published. Required fields are marked *